CMS Administrator Marilyn Tavenner said during a congressional hearing that the agency has no interest in re-introducing a series of controversial Part D policies it had proposed and then rescinded earlier this year. Her comments on Thursday (Sept. 18), the same day CMS released details on the Part D landscape for 2015. CMS in March put on hold policies from a proposed regulation that would have reduced the number of Medicare protected drug classes, opened up preferred pharmacy networks, limited...